Is Chonluten FDA approved?
No. This profile records Chonluten as not FDA approved and for research use only.
MORE CONTEXT ›
Review the regulatory and source details on this page for the current context.
Healing CATEGORY
Chonluten
THE BREATH ENHANCER
Peptide Complex AC-7
Chonluten is a synthetic tripeptide (Glu-Asp-Gly) designed to support respiratory health. It works by penetrating lung cells and modifying gene expression to restore the epithelial lining, reduce inflammation, and improve surfactant production. It's particularly useful for chronic respiratory conditions and age-related lung decline.
Chonluten
Chonluten
Chonluten
Chonluten Evidence Snapshot
How these guides are reviewed
REGULATORY STATUS
Not FDA approved · research use only
DOSING GUIDANCE
Reviewed by our clinical team
LINKED EVIDENCE
1 research sources
CONTENT UPDATED
May 8, 2026
Dose and schedule recommendations shown below come from The Peptide App Clinical Team. Research links are provided so readers can inspect the supporting evidence directly. Review the sources.
Quick Answers About Chonluten
What dose does The Peptide App Clinical Team recommend for Chonluten?
Dose: 30 mg daily (oral or subcutaneous).
MORE CONTEXT ›
Schedule: daily. Cycle: 4 weeks on, 8 weeks off. This is clinical-team guidance for reference and does not replace individualized instructions from a licensed clinician.
What research supports this Chonluten guide?
This guide links to 1 curated or current research sources.
MORE CONTEXT ›
Open the research section to inspect the source titles, publication details, study types, and available abstracts directly.
Studied Effects & Mechanisms
Gene Regulation
Modifies lung cell gene expression for tissue repair
Epithelial Repair
Restores the protective lining of airways
Anti-Inflammatory
Reduces lung inflammation and fibrotic markers
People with chronic respiratory conditions
Smokers or former smokers
Those recovering from lung infections
Aging individuals with declining lung function
Anyone wanting to protect lung health
Chonluten Research
Live research temporarily unavailableThe live research feed did not return papers for this page. The curated references below remain available for crawlable source context.
RESEARCH REFERENCES